Oppenheimer Analyst Ratings & Stock Recommendations (NYSE:OPY)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Oppenheimer. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Oppenheimer.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
11/12/2018OppenheimerInitiatesAerie Pharmaceuticals (AERI)Buy $64.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerInitiatesBiohaven Pharmaceutical (BHVN)Buy $63.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetMesoblast (MESO)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetJuniper Networks (JNPR)Buy $33.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerReiteratesFlowserve (FLS)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetSLM (SLM)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerReiteratesAxovant Sciences (AXON)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerInitiatesSpero Therapeutics (SPRO)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetSynlogic (SYBX)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetAlpine Immune Sciences (ALPN)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetAduro BioTech (ADRO)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetSorrento Therapeutics (SRNE)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetMirati Therapeutics (MRTX)Buy $57.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetTESARO (TSRO)Buy $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerReiteratesProthena (PRTA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetCenturylink (CTL)Outperform$24.00 -> $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetZayo Group (ZAYO)Outperform $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetGTT Communications (GTT)Outperform $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetStryker (SYK)Hold $170.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetGlobus Medical (GMED)Hold $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetActivision Blizzard (ATVI)Outperform$87.00 -> $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetSkyworks Solutions (SWKS)Outperform$120.00 -> $110.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetTandem Diabetes Care (TNDM)Buy $57.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetSeres Therapeutics (MCRB)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetThe Medicines (MDCO)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetVolitionRX (VNRX)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerReiteratesPra Group (PRAA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetBIOLINERX Ltd/S (BLRX)Buy $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerRaises TargetHubSpot (HUBS)Outperform$150.00 -> $160.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerRaises TargetCyberark Software (CYBR)Outperform$75.00 -> $89.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerRaises TargetChurch & Dwight (CHD)Outperform$66.00 -> $73.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerReiteratesDenbury Resources (DNR)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetEvofem Biosciences (EVFM)Buy $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy$60.00 -> $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetWright Medical Group (WMGI)Hold $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetRecro Pharma (REPH)Buy $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetVanda Pharmaceuticals (VNDA)Buy $29.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerReiteratesEncore Capital Group (ECPG)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerReiteratesVector Group (VGR)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerLowers TargetTurtle Beach (HEAR)Outperform$35.00 -> $24.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerRaises TargetAddus Homecare (ADUS)Outperform$72.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetCompugen (CGEN)Buy $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetRadware (RDWR)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetCDK Global (CDK)Buy $67.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerDowngradesEndurance International Group (EIGI)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerReiteratesQEP Resources (QEP)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetGlobal Blood Therapeutics (GBT)Buy$74.00 -> $82.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetDexCom (DXCM)Buy $150.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerReiteratesTeva Pharmaceutical Industries (TEVA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerReiteratesDiamondback Energy (FANG)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerReiteratesAllot Communications (ALLT)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerSet Price TargetForterra (FRTA)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerSet Price TargetServicemaster Global (SERV)Buy $47.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerReiteratesMueller Water Products (MWA)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetFrontdoor (FTDR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetAmerican Express (AXP)Buy $114.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetCeragon Networks (CRNT)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerReiteratesWatts Water Technologies (WTS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetSAGE Therapeutics (SAGE)Buy $170.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetVistagen Therapeutics (VTGN)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetStoneCastle Financial (BANX)Buy $24.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetGulfport Energy (GPOR)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerRaises TargetStarbucks (SBUX)Outperform$61.00 -> $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerSet Price TargetEndologix (ELGX)Hold $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerReiteratesbluebird bio (BLUE)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerSet Price TargetAres Management LP Unit (ARES)Buy $28.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerSet Price TargetEpizyme (EPZM)Buy $27.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerSet Price TargetInsulet (PODD)Hold $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerReiteratesIon Geophysical (IO)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerReiteratesCarbonite (CARB)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerReiteratesITT (ITT)Buy $68.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerReiteratesSynchrony Financial (SYF)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetTESARO (TSRO)Buy $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetCaesars Entertainment (CZR)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetExelixis (EXEL)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerSet Price TargetCTI BioPharma (CTIC)Buy $4.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerSet Price TargetTandem Diabetes Care (TNDM)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetConstellation Pharmaceuticals (CNST)Buy $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetAzurRx BioPharma (AZRX)Buy $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetGlobal Blood Therapeutics (GBT)Buy $74.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetSyros Pharmaceuticals (SYRS)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerReiteratesAgios Pharmaceuticals (AGIO)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetConforMIS (CFMS)Buy $3.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetAres Capital (ARCC)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetWyndham Destinations (WYND)Buy $66.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerInitiatesSLS International (SLS)Outperform $13.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerReiteratesTeva Pharmaceutical Industries (TEVA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerReiteratesNoble Energy (NBL)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerSet Price TargetApollo Global Management (APO)Buy $43.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerReiteratesSantander Consumer USA (SC)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerSet Price TargetForterra (FRTA)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018OppenheimerSet Price TargetEnPro Industries (NPO)Buy $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerSet Price TargetKemPharm (KMPH)Buy $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerSet Price TargetThe Carlyle Group (CG)Buy $34.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerReiteratesClean Harbors (CLH)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerSet Price TargetIntercept Pharmaceuticals (ICPT)Hold $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerReiteratesAdvanced Disposal Services (ADSW)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerReiteratesMatador Resources (MTDR)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerReiteratesIntegra Lifesciences (IART)Buy $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerReiteratesIntellia Therapeutics (NTLA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerLowers TargetFacebook (FB)Outperform$200.00 -> $185.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerSet Price TargetAmgen (AMGN)Buy $224.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerSet Price TargetAduro BioTech (ADRO)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerReiteratesNCR (NCR)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018OppenheimerSet Price TargetWaste Connections (WCN)Buy $87.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerSet Price TargetAmeresco (AMRC)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerSet Price TargetMustang Bio (MBIO)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerSet Price TargetMirati Therapeutics (MRTX)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerReiteratesA. O. Smith (AOS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerSet Price TargetWyndham Hotels & Resorts (WH)Buy $69.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerDowngradesLumber Liquidators (LL)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerSet Price TargetCredit Acceptance (CACC)Buy $420.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerReiteratesXylem (XYL)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerReiteratesCummins (CMI)Buy $164.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerSet Price TargetSAGE Therapeutics (SAGE)Buy $170.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerSet Price TargetAllison Transmission (ALSN)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018OppenheimerReiteratesEnerSys (ENS)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerReiteratesViper Energy Partners (VNOM)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerReiteratesGraco (GGG)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerReiteratesAmazon.com (AMZN)Buy$2,130.00 -> $2,020.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerReiteratesIntel (INQ)NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerReiteratesMicrosoft (MSFT)Buy $127.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerReiteratesDenbury Resources (DNR)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/28/2018OppenheimerSet Price TargetBiogen (BIIB)Buy$400.00 -> $380.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018OppenheimerSet Price TargetZimmer Biomet (ZBH)Buy $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerRaises TargetSPS Commerce (SPSC)Outperform -> Outperform$85.00 -> $95.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerRaises TargetService Co. International (SCI)Outperform -> Outperform$42.00 -> $47.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerRaises TargetOmnicell (OMCL)Outperform -> Outperform$71.00 -> $73.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerLowers TargetEllie Mae (ELLI)Outperform -> Outperform$125.00 -> $92.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerLowers TargetCorelogic (CLGX)Outperform -> Outperform$53.00 -> $46.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerUpgradesTwitter (TWTR)Market Perform -> Outperform $37.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerLowers TargetPolyOne (POL)Outperform$50.00 -> $43.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerSet Price TargetStryker (SYK)Hold $170.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerSet Price TargetAlly Financial (ALLY)Buy $32.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018OppenheimerReiteratesRepublic Services (RSG)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerSet Price TargetKKR & Co Inc (KKR)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerSet Price TargetHewlett Packard Enterprise (HPE)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerReiteratesPioneer Natural Resources (PXD)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerReiteratesTesla (TSLA)Buy $418.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerSet Price TargetKemPharm (KMPH)Buy $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerReiteratesColfax (CFX)Buy$42.00 -> $37.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerReiteratesNavient (NAVI)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerReiteratesBorgWarner (BWA)Buy $51.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerReiteratesWaste Management (WM)Buy $95.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018OppenheimerReiteratesLincoln Electric (LECO)Buy $95.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/24/2018OppenheimerSet Price TargetIngevity (NGVT)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/24/2018OppenheimerSet Price TargetBoston Scientific (BSX)Hold $38.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018OppenheimerSet Price TargetJuniper Networks (JNPR)Buy $33.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018OppenheimerSet Price TargetCapital One Financial (COF)Buy $101.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/24/2018OppenheimerReiteratesCarlisle Companies (CSL)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/24/2018OppenheimerSet Price TargetSix Flags Entertainment (SIX)Buy $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018OppenheimerReiteratesCaterpillar (CAT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018OppenheimerSet Price TargetExpedia Group (EXPE)Buy $155.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018OppenheimerSet Price TargetCtrip.Com International (CTRP)Buy $47.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018OppenheimerReiteratesDover (DOV)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018OppenheimerReiteratesSynchrony Financial (SYF)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018OppenheimerReiteratesQEP Resources (QEP)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018OppenheimerSet Price TargetMicrosoft (MSFT)Buy $127.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018OppenheimerInitiatesBlackline (BL)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018OppenheimerInitiatesModel N (MODN)Outperform $23.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018OppenheimerSet Price TargetGulfport Energy (GPOR)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018OppenheimerSet Price TargetBiogen (BIIB)Buy $400.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018OppenheimerReiteratesAlliance Data Systems (ADS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018OppenheimerSet Price TargetEiger Biopharmaceuticals (EIGR)Buy $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018OppenheimerReiteratesAmerican Express (AXP)Buy $114.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018OppenheimerSet Price TargetNetflix (NFLX)Buy$370.00 -> $410.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018OppenheimerUpgradesU.S. Bancorp (USB)Market Perform -> Outperform $62.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018OppenheimerUpgradesNike (NKE)Market Perform -> Outperform $90.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerSet Price TargetITT (ITT)Buy $67.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerInitiatesBJs Wholesale Club (BJ)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerSet Price TargetADMA Biologics (ADMA)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerRaises TargetUnitedHealth Group (UNH)Outperform$276.00 -> $295.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerLowers TargetW W Grainger (GWW)Outperform$410.00 -> $365.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/16/2018OppenheimerSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/16/2018OppenheimerReiteratesMatador Resources (MTDR)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerReiteratesTeva Pharmaceutical Industries (TEVA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerInitiatesSAGE Therapeutics (SAGE)Buy $170.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerInitiatesAzurRx BioPharma (AZRX)Outperform $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018OppenheimerInitiatesMongodb (MDB)Outperform $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/16/2018OppenheimerUpgradesMorgan Stanley (MS)Outperform $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/16/2018OppenheimerSet Price TargetBlackstone Group (BX)Buy $44.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/16/2018OppenheimerSet Price TargetApollo Global Management (APO)Buy $43.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/16/2018OppenheimerSet Price TargetThe Carlyle Group (CG)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/14/2018OppenheimerReiteratesDonaldson (DCI)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018OppenheimerReiteratesAcelRx Pharmaceuticals (ACRX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018OppenheimerSet Price TargetKemPharm (KMPH)Buy $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/10/2018OppenheimerInitiatesSAGE Therapeutics (SAGE)Buy $170.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/10/2018OppenheimerRaises TargetRexnord (RXN)Outperform -> Buy$35.00 -> $37.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/9/2018OppenheimerReiteratesAcelRx Pharmaceuticals (ACRX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018OppenheimerSet Price TargetIntercept Pharmaceuticals (ICPT)Hold $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/5/2018OppenheimerRaises TargetPetIQ (PETQ)Outperform$28.00 -> $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/5/2018OppenheimerReiteratesAlliance Data Systems (ADS)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
10/5/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018OppenheimerRaises TargetEnerSys (ENS)Outperform -> Outperform$86.00 -> $95.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018OppenheimerReiteratesCarlisle Companies (CSL)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018OppenheimerSet Price TargetAlly Financial (ALLY)Outperform -> Buy$34.00 -> $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerRaises TargetWillScot (WSC)Outperform -> Outperform$18.00 -> $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerReiteratesEndologix (ELGX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesWhiting Petroleum (WLL)Outperform $67.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesViper Energy Partners (VNOM)Outperform $51.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerReiteratesVector Group (VGR)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesQEP Resources (QEP)Outperform $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesPioneer Natural Resources (PXD)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesPDC Energy (PDCE)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesOasis Petroleum (OAS)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesNoble Energy (NBL)Market Perform $43.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesMatador Resources (MTDR)Outperform $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesGulfport Energy (GPOR)Outperform $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesDiamondback Energy (FANG)Outperform $166.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesDenbury Resources (DNR)Outperform $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesCarrizo Oil & Gas (CRZO)Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerInitiatesCallon Petroleum (CPE)Outperform $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018OppenheimerSet Price TargetVanda Pharmaceuticals (VNDA)Buy $29.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerLowers TargetServicemaster Global (SERV)Outperform$65.00 -> $47.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerReiteratesAmgen (AMGN)Buy $224.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerReiteratesGeneral Electric (GE)NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerReiteratesIntegra Lifesciences (IART)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerDowngradesEncore Capital Group (ECPG)Outperform -> Hold $54.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerRaises TargetCentene (CNC)Outperform -> Outperform$146.00 -> $158.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerInitiatesFrontdoor (FTDR)Outperform $48.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerSet Price TargetADMA Biologics (ADMA)Buy $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018OppenheimerReiteratesWatts Water Technologies (WTS)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018OppenheimerUpgradesLogMeIn (LOGM)Market Perform -> Outperform $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018OppenheimerReiteratesApple (AAPL)NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018OppenheimerReiteratesTesla (TSLA)Buy $385.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/30/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018OppenheimerSet Price TargetConatus Pharmaceuticals (CNAT)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018OppenheimerDowngradesChipotle Mexican Grill (CMG)Market Perform -> Underperform $400.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018OppenheimerSet Price TargetMicrosoft (MSFT)Buy $127.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/30/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018OppenheimerRaises TargetTeladoc Health (TDOC)Outperform -> Outperform$68.00 -> $89.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018OppenheimerRaises TargetIntuit (INTU)Outperform -> Outperform$224.00 -> $239.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018OppenheimerUpgradesCeragon Networks (CRNT)Market Perform -> Outperform $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018OppenheimerRaises Targetsalesforce.com (CRM)Outperform -> Outperform$160.00 -> $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018OppenheimerRaises TargetChurch & Dwight (CHD)Outperform -> Outperform$60.00 -> $66.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018OppenheimerReiteratesNike (NKE)NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018OppenheimerRaises TargetLululemon Athletica (LULU)Outperform -> Outperform$180.00 -> $190.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018OppenheimerRaises TargetHoneywell International (HON)Outperform$172.00 -> $184.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018OppenheimerRaises TargetFortinet (FTNT)Outperform$82.00 -> $97.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018OppenheimerSet Price TargetKKR & Co Inc (KKR)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018OppenheimerUpgradesGoPro (GPRO)Market Perform -> Outperform $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/25/2018OppenheimerReiteratesMotus GI (MOTS)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
9/25/2018OppenheimerRaises TargetBarnes Group (B)Outperform$75.00 -> $82.00LowView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Monday at 11:23 PM ET.

MarketBeat Community Rating for Oppenheimer

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  183 (Vote Underperform)
Total Votes:  342
MarketBeat's community ratings are surveys of what our community members think about Oppenheimer and other research firms. Vote "Outperform" if you believe Oppenheimer's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Oppenheimer's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel